Sr. Director, Epidemiology and RWE Analytics

Who We Are:

At Neurocrine Biosciences, we pride ourselves on having a strong, inclusive, and positive culture based on our shared purpose and values. We know what it takes to be great, and we are as passionate about our people as we are about our purpose - to relieve suffering for people with great needs.

What We Do:

Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X and Facebook. (*in collaboration with AbbVie)

About the Role:

The Senior Director, Epidemiology will lead efforts in epidemiology and observational research to support reimbursement evaluations, post-marketing safety surveillance, and clinical development. This role also provides quantitative support, from data to analytics, to Health Economics and Outcomes Research (HEOR). Working with partners, this role will leverage data and analytics to inform health technology assessments (HTA) and reimbursement submissions. The Senior Director will work cross-functionally to ensure robust epidemiological methods and RWE analytics are integrated into research and development processes, ultimately influencing policy and reimbursement strategy to enhance market access viability.

_

Your Contributions (include, but are not limited to):

• Observational Research, RWE, and Epidemiology

  • Lead epidemiological studies to provide evidence supporting reimbursement evaluation, post-marketing safety surveillance, and clinical development.

  • Design, conduct, and interpret epidemiology studies to inform decision-making throughout the product lifecycle.

  • Ensure rigorous epidemiological methodologies are applied in the collection and analysis of real-world data.

• Quantitative HEOR Support:

  • Provide quantitative support and analysis for HEOR initiatives, enhancing the credibility and impact of economic evaluations.

  • Collaborate with HEOR teams to develop models and analyses that demonstrate the value, cost-effectiveness, and budget impact of products.

• HTA and Reimbursement Support:

  • With expertise in data and analytics, partner with HEOR teams to shape strategies to support health technology assessments (HTA) and reimbursement submissions.

  • Engage with key stakeholders, including HEOR, market access, to advocate for favorable reimbursement outcomes.

  • Integrate RWE and epidemiological data into reimbursement dossiers to support product value arguments.

• Cross-Functional Collaboration: